![Hideki Takeda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 947 123 $ in data 31/07/2026
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PRISM BioLab Co., Ltd.
 PRISM BioLab Co., Ltd. BiotechnologyHealth Technology Provides drug discovery and development services using proprietary platform technology 2,53% | 31/03/2026 | 935.000 ( 2,53% ) | 910 194 $ | 31/07/2026 |
| 31/12/2025 | 196.000 ( 0,19% ) | 36 928 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | 01/01/2016 |
Medical Patent Research, Inc. | Direttore/Membro del Consiglio | 01/01/2009 |
Ctex Co. Ltd. | Direttore/Membro del Consiglio | 01/02/2018 |
Scent Science International, Inc.
 Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Fondatore | 23/07/2010 |
Liid Pharmaceuticals, Inc. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Osaka University
 Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Producer Manufacturing |
Modalis Therapeutics Corp.
 Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Medical Patent Research, Inc. | |
Ctex Co. Ltd. | |
Liid Pharmaceuticals, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
